Showing results (511-520 of 640) with videos related to
Sort By:
Pageof 64
Urologic Oncology|July 14, 2007
Difficult decisions in urologic oncology: management of high-grade T1 transitional cell carcinoma of the bladderMark S Soloway, Cheryl T Lee, Gary D Steinberg, et al.Urology Case Reports|November 15, 2021
Diffuse large B-cell lymphoma presenting as LUTS: Clinical practice pointsSoum D Lokeshwar, Syed N Rahman, Jamil Syed, et al.Urology|November 8, 2011
Prostate sampling by 12-core biopsy: comparison of the biopsy results with tumor location in prostatectomy specimensViacheslav Iremashvili, Liset Pelaez, Merce Jorda, et al.The American Journal of Surgical Pathology|October 1, 1994
Clinical and pathobiological effects of neoadjuvant total androgen ablation therapy on clinically localized prostatic adenocarcinomaO A Armas, A G Aprikian, J Melamed, et al.Journal of the National Cancer Institute|January 6, 1993
Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progressionA S Sarkis, G Dalbagni, C Cordon-Cardo, et al.Urology|August 1, 1990
Surgical treatment of brain metastases from renal cell carcinomaR A Badalament, R W Gluck, G Y Wong, et al.Cancer|July 1, 1987
Testicular failure in patients with extragonadal germ cell tumorsP R Carroll, W F Whitmore, M Richardson, et al.Cancer|June 15, 1987
The sensitivity of flow cytometry compared with conventional cytology in the detection of superficial bladder carcinomaR A Badalament, M Kimmel, H Gay, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1977
Carbon-11-labeled methylated polyamine analogs: uptake in prostate and tumor in animal modelsM J Welch, R E Coleman, M G Straatmann, et al.Cancer|October 1, 1987
The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinomaR A Badalament, D K Hermansen, M Kimmel, et al.Pageof 64